Medication safety: Getting We will decrease the We will report on the numbers medication prescribing and percentage of incidents and types of medication administration right for documented as causing harm errors, and the corrective patients is essential to a by a further 2 percentage action being taken, in our speedy recovery. points to 3.5%. monthly ‘Performance Assurance Framework’ We will decrease the number (reviewed by senior of reports of omitted / delayed staff). Our Trust Board doses from 26% to under 15% will also receive a full report of ‘serious incidents’ at each We will improve our meeting. prescribing practice by involving doctors in root cause analysis of the incidents they are involved in. We will continue to measure our compliance with prescribing standards. We will improve our education and training on safe and effective use of medicines – achieved by training analysis and strategy development, monitored via progress with strategy action plan We will increase our We will introduce Schwartz We will continue to monitor mechanisms to hear expert rounds to ensure that staff what our staff say via our Staff staff and user views on the concerns about the quality of Experience & Engagement safety of the care that we care are listened to. Committee. We will monitor provide. what patients tell us via our We will introduce first hand Patient Experience Review Using a variety of methods to patient stories to Board Group. Both of these do so will strengthen our meetings committees then report to our confidence in the quality of Quality & Governance care we provide. Committee.
Medication safety: Getting medication prescribing and administration right for patients is essential to a speedy recovery. We will decrease the percentage of incidents documented as causing harm by a further 2 percentage points to 3.5%. We will decrease the number of reports of omitted / delayed doses from 26% to under 15% We will improve our prescribing practice by involving doctors in root cause analysis of the incidents they are involved in. We will continue to measure our compliance with prescribing standards. We will improve our education and training on safe and effective use of medicines – achieved by training analysis and strategy development, monitored via progress with strategy action plan We will report on the numbers and types of medication errors, and the corrective action being taken, in our monthly ‘Performance Assurance Framework’ (reviewed by senior staff). Our Trust Board will also receive a full report of ‘serious incidents’ at each meeting. We will increase our mechanisms to hear expert staff and user views on the safety of the care that we provide. Using a variety of methods to do so will strengthen our confidence in the quality of care we provide. We will introduce Schwartz rounds to ensure that staff concerns about the quality of care are listened to. We will introduce first hand patient stories to Board meetings We will continue to monitor what our staff say via our Staff Experience & Engagement Committee. We will monitor what patients tell us via our Patient Experience Review Group. Both of these committees then report to our Quality & Governance Committee.
Quality%20Account%202014-15%20Final%2026.06.15.docx